Son's Autism Forces Family to Leave Canada – Video

27-03-2012 22:28 http://www.ctvvancouverisland.ca http UVIC -- A popular professor at the University of Victoria is leaving his job and the country after his son's medical condition lead to immigration problems. In 2010 Dr. Jeffrey Niehaus' son was diagnosed with autism spectrum disorder. His family was working to become Canadian citizens but the boy's health condition proved to be a roadblock. In a letter from Immigration Canada, an officer told Dr. Niehaus his son was, "a person whose health condition might reasonably be expected to cause excessive demand on health or social services in Canada". As a result, his application for permanent residency was denied. The University of Victoria hired a lawyer to appeal the decision but the effort fell short. In preparation of his work Visa expiring in November, Dr. Niehaus applied for jobs and accepted a position in Virginia. Despite wanting to keep the story from media, Dr. Niehaus says his family has made up its mind and is leaving. It's why he is now content telling his story: "I'm much more comfortable with the idea that our story would be an example for people interested in how their own government works. People could use this as perhaps a way to have some positive influence going forward". Dr. Niehaus says he's not angry. In November he plans to take his family back to the United States where they will live permanently. Follow Joe Perkins on Twitter: http://www.twitter.com

Visit link:
Son's Autism Forces Family to Leave Canada - Video

Son’s Autism Forces Family to Leave Canada – Video

27-03-2012 22:28 http://www.ctvvancouverisland.ca http UVIC -- A popular professor at the University of Victoria is leaving his job and the country after his son's medical condition lead to immigration problems. In 2010 Dr. Jeffrey Niehaus' son was diagnosed with autism spectrum disorder. His family was working to become Canadian citizens but the boy's health condition proved to be a roadblock. In a letter from Immigration Canada, an officer told Dr. Niehaus his son was, "a person whose health condition might reasonably be expected to cause excessive demand on health or social services in Canada". As a result, his application for permanent residency was denied. The University of Victoria hired a lawyer to appeal the decision but the effort fell short. In preparation of his work Visa expiring in November, Dr. Niehaus applied for jobs and accepted a position in Virginia. Despite wanting to keep the story from media, Dr. Niehaus says his family has made up its mind and is leaving. It's why he is now content telling his story: "I'm much more comfortable with the idea that our story would be an example for people interested in how their own government works. People could use this as perhaps a way to have some positive influence going forward". Dr. Niehaus says he's not angry. In November he plans to take his family back to the United States where they will live permanently. Follow Joe Perkins on Twitter: http://www.twitter.com

Visit link:
Son's Autism Forces Family to Leave Canada - Video

Diagnosis, screening behind rise in autism

ATLANTA Autism cases are on the rise again, largely due to wider screening and better diagnosis, federal health officials said Thursday.

Don't miss these Health stories

Where's the one place you should never kiss a baby -- or anyone else? The ear, according to a professor of audiology at Hofstra University in Hempstead, N.Y.

The rate of U.S. cases of autism and related disorders rose to about 1 in 88 children. The previous estimate was 1 in 110.

The new figure is from the latest in a series of studies that have been steadily increasing the government's autism estimate. This new number means autism is nearly twice as common as officials said it was only five years ago, and likely affects roughly 1 million U.S. children and teens.

Health officials attribute the increase largely to better recognition of cases, through wide screening and better diagnosis. But the search for the cause of autism is really only beginning, and officials acknowledge that other factors may be helping to drive up the numbers.

"We're not quite sure the reasons for the increase," said Coleen Boyle of the Centers for Disease Control and Prevention.

Autism is diagnosed by making judgments about a child's behavior; there are no blood or biologic tests. For decades, the diagnosis was given only to kids with severe language and social impairments and unusual, repetitious behaviors. The definition of autism has gradually expanded, and "autism" is now shorthand for a group of milder, related conditions, including Asperger's syndrome. Meanwhile, there's been an explosion in autism-related treatment and services for children.

As in the past, advocacy groups seized on the new numbers as further evidence that autism research and services should get greater emphasis. The new figures indicate "a public health emergency that demands immediate attention," said Geraldine Dawson, chief science officer for the advocacy group Autism Speaks.

The CDC study released Thursday is considered the most comprehensive U.S. investigation of autism prevalence to date. Researcher gathered data from areas in 14 states Alabama, Arizona, Arkansas, Colorado, Florida, Georgia, Maryland, Missouri, New Jersey, North Carolina, Pennsylvania, South Carolina, Utah and Wisconsin.

Follow this link:
Diagnosis, screening behind rise in autism

Autism On The Rise: 5 Key Facts About The New Research

The number of autism cases in the United States has reached one in every 88 children, the U.S. Center for Disease Control (CDC) reports. This is a 78 percent rise from ten years ago.

Autism is a developmental disorder that manifests itself in many ways. It is typically diagnosed in children between the ages of one and eight. Symptoms often -- but not always -- include slow language development, persistent fixations and difficulties with social interactions.

In part, the sharp increase in autism cases is due to the fact that awareness has grown, leading to more correct diagnoses. But it may also reflect an actual increase in the number of people affected by the disorder. "We're not quite sure the reasons for the increase," Coleen Boyle of the CDC, said to the Associated Press.

More research will determine what's really behind the data -- in the meantime, autism awareness advocacy groups are taking this opportunity to call attention to the disorder's prevalence in society.

"The CDC numbers are alarming, yet they don't begin to tell the story of the real families, real individuals struggling every day," said Mark Roithmayr, president of Autism Speaks, in a statement on the organization's website.

Like us on Facebook

Here are five facts about autism that shed light on the new research.

Diagnoses are not evenly spread across the board.

Autism is much more common in boys than in girls; a full five times as many males are affected by the disorder. In addition, certain states seem to have a preponderance of autism cases. The CDC study found that just one in 210 children in Alabama were affected, as opposed to 1 in 47 in Utah. And the biggest growth in diagnoses over the last few years was among black and Hispanic children. Of course, this may not suggest an actual difference between ethnicities or locations; it could be due instead to changes in medical practices in certain communities over the years.

The word 'autism' can mean many things.

Read more from the original source:
Autism On The Rise: 5 Key Facts About The New Research

Autism: More Kids than Ever Are Diagnosed, but Is the Increase Real?

Charly Franklin / Getty Images

Autism rates continue to rise, according to a new government survey, but the skyrocketing figures dont necessarily mean the disorder is increasing.

According to the latest estimate, released on Thursday by the Centers for Disease Control and Prevention (CDC), 1 in 88 children in the U.S. has an autism spectrum disorder (ASD) a nearly 25% increase from 2006, when the rate was 1 in 110, and a stunning 78% increase since 200002, when the CDC first began tracking the disorder and estimated the rate at 1 in 150 children.

(VIDEO: How Ballet Can Help Kids with Autism)

Much of the surge, experts acknowledge, may be due to better diagnosis, wider awareness and broader definitions of autism. Autism used to be diagnosed only in children with severe language and social problems and repetitive behaviors, but several years ago, researchers expanded the criteria for diagnosis to also include autism spectrum disorders a wider range of developmental conditions associated with autism. These conditions include Aspergers syndrome, which describes children who are high functioning but exhibit milder symptoms of social impairment or learning problems, and pervasive developmental disorder not otherwise specified (PDD-NOS), a diagnosis that is easier to get.

Greater awareness of autism by parents, doctors and school administrators, along with a growing push to help all affected children learn and socialize, may also be fueling the uptick. Doctors have gotten better at diagnosing the condition, and communities have gotten better at providing services for those affected by autism, Dr. Thomas Frieden, director of the CDC, told reporters in a conference call. At this point, I think its a possibility that the increase in identification of autism is entirely the result of better detection. We dont know whether or not that is the case, but it is a possibility.

Mark Roithmayr, president of Autism Speaks, an autism research and advocacy group, concedes that such factors may figure into the swelling of cases but argues that they likely account for only about half the increase. Only part of the increase can be explained by better and broader diagnoses, he said on the same call. There is a great unknown. Something is going on here, and we dont know.

(MORE: Environmental Factors May Be Just as Important as Genes in Autism)

The latest CDC numbers come from the Autism and Developmental Disabilities Monitoring Network, a comprehensive program covering 14 states, in which trained reviewers examine medical and school records of 8-year-olds for descriptions or diagnoses of autism or ASDs.

Tracking the prevalence of autism has always been controversial, and experts still cant agree on exactly how common the disorder is, since its definition continues to shift. The rate may drop again by years end, when a new definition of autism is slated to be included in the fifth revision of the standard manual for mental illness, the DSM-V; the updated definition is expected to focus more exclusively on core autism cases and exclude Aspergers and PDD-NOS, which a growing number of experts believe to be distinct from true autism. The current CDC analysis did not break down ASD diagnoses by subtype.

Read the original:
Autism: More Kids than Ever Are Diagnosed, but Is the Increase Real?

Autism rates up; screening, better diagnosis cited

ATLANTA (AP) -- Autism cases are on the rise again, largely due to wider screening and better diagnosis, federal health officials said Thursday.

The rate of U.S. cases of autism and related disorders rose to about 1 in 88 children. The previous estimate was 1 in 110.

The new figure is from the latest in a series of studies that have been steadily increasing the government's autism estimate. This new number means autism is nearly twice as common as officials said it was only five years ago, and likely affects roughly 1 million U.S. children and teens.

Health officials attribute the increase largely to better recognition of cases, through wide screening and better diagnosis. But the search for the cause of autism is really only beginning, and officials acknowledge that other factors may be helping to drive up the numbers.

"We're not quite sure the reasons for the increase," said Coleen Boyle of the Centers for Disease Control and Prevention.

Autism is diagnosed by making judgments about a child's behavior; there are no blood or biologic tests. For decades, the diagnosis was given only to kids with severe language and social impairments and unusual, repetitious behaviors. The definition of autism has gradually expanded, and "autism" is now shorthand for a group of milder, related conditions, including Asperger's syndrome. Meanwhile, there's been an explosion in autism-related treatment and services for children.

As in the past, advocacy groups seized on the new numbers as further evidence that autism research and services should get greater emphasis. The new figures indicate "a public health emergency that demands immediate attention," said Geraldine Dawson, chief science officer for the advocacy group Autism Speaks.

The CDC study released Thursday is considered the most comprehensive U.S. investigation of autism prevalence to date. Researcher gathered data from areas in 14 states Alabama, Arizona, Arkansas, Colorado, Florida, Georgia, Maryland, Missouri, New Jersey, North Carolina, Pennsylvania, South Carolina, Utah and Wisconsin.

They looked specifically at 8-year-old children because most autism is diagnosed by that age. They checked health and school records to see which children met the criteria for autism, even if they hadn't been formally diagnosed. Then, the researchers calculated how common autism was in each place and overall.

An earlier report based on 2002 findings estimated that about 1 in 150 children that age had autism or a related disorder such as Asperger's. After seeing 2006 data, the figure was revised to about 1 in 110. The estimate released Thursday, based on 2008 data, is 1 in 88.

See the original post:
Autism rates up; screening, better diagnosis cited

CEO of stem cell company responds to FDA warning letter

The head of a stem cell company has responded to a warning letter issued by the U.S. Food and Drug Administration that cites several violations at the company that derives stem cells from adipose tissue or body fat.

Dr. Steven Victor of IntelliCell BioSciences said it would be moving to a new facility next month that it believes will address the current good manufacturing practice issues referred to in the warning letter It has also hired consultants with FDA-compliance experience that will help bring its new facilities in compliance with the FDA. Victor added that the company will address all of the FDAs observations on April 3.

The New York company received a warning letter dated March 13 that was published on the FDAs website yesterday. The letter said that the process that the company uses to produce stem cells from adipose tissue did not meet the FDAs definition of minimal manipulation for structural tissue such as adipose tissue.

The rest is here:
CEO of stem cell company responds to FDA warning letter

RBCC: Michael J. Fox Foundation Invests $179 Million in the Fight Against Parkinson’s Disease

NOKOMIS, Fla.--(BUSINESS WIRE)--Parkinsons disease is the core focus of the The Michael J. Fox Foundation. Rainbow BioSciences (OTCBB: RBCC) intends to join the Foundation in the fight against Parkinsons disease when it signs a letter of intent with an advanced therapy developer within the next few days, and with good reason: There could be 12 million people suffering from the disease by 2032.

Thanks in no small part to the high profile of its A-list namesake, the Michael J. Fox Foundation has over the past 12 years become the largest private funder of Parkinson's disease research in the world, investing nearly $179 million in research to date. Through its aggressive outreach work, the Foundation has realized unprecedented success in raising awareness of the disease and its effects around the world.

Though the global market for Parkinsons treatments is $3 billion and growing, there are currently no drugs or therapies available that are capable of stopping or slowing the diseases progression. With RBCCs focus on this devastating disease, effective new emerging therapies are on the horizon.

For more information on Rainbow BioSciences, RBCCs biotechnology division, please visit http://www.rainbowbiosciences.com/investors.

Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Cell Therapeutics, Inc. (NASDAQ:CTIC),Biogen Idec Inc. (NASDAQ:BIIB), Abbott Laboratories (NYSE:ABT) and Elan Corp. (NYSE:ELN).

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.RainbowBioSciences.com]. For investment information and performance data on the company, please visit http://www.RainbowBioSciences.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

More:
RBCC: Michael J. Fox Foundation Invests $179 Million in the Fight Against Parkinson’s Disease

Muhammad Ali's Celebrity Fight Night targets disease

by Philip Haldiman - Mar. 25, 2012 10:08 PM The Republic | azcentral.com

Everybody knows that Muhammad Ali floats like a butterfly and stings like a bee.

But he can also throw a pretty mean fundraising party.

Celebrity Fight Night has raised more than $70 million since it started in 1994, when celebrities first donned oversize boxing gloves and duked it out for the fight against Parkinson's disease in front of 400 people.

Celebrity Fight Night in Phoenix

Now a mainstay of fundraising events in the Valley, this year the gala set a record with 1,300 people in attendance and raised more than $9.1 million Saturday at JW Marriott Desert Ridge Resort and Spa in north Phoenix.

The money raised will go to the Muhammad Ali Parkinson Center at St. Joseph's Barrow Neurological Institute, as well as other charities.

The 10,000-square-foot facility, established in 1997 and named after the former heavyweight boxing champion, who was diagnosed with Parkinson's in 1984, is on the campus of St. Joseph's Hospital and Medical Center in Phoenix.

The progressive disorder of the brain can cause tremors, rigidity, poor posture and coordination, and difficulty performing voluntary movements.

Saturday's Fight Night XVIII was a black-tie affair featuring stars from many walks of life -- athletes, actors and comedians -- mingling with Valley residents. Celebrities like Evander Holyfield, Billy Crystal, Bo Derek and Kurt Warner walked the red carpet.

Go here to see the original:
Muhammad Ali's Celebrity Fight Night targets disease

Muhammad Ali’s Celebrity Fight Night targets disease

by Philip Haldiman - Mar. 25, 2012 10:08 PM The Republic | azcentral.com

Everybody knows that Muhammad Ali floats like a butterfly and stings like a bee.

But he can also throw a pretty mean fundraising party.

Celebrity Fight Night has raised more than $70 million since it started in 1994, when celebrities first donned oversize boxing gloves and duked it out for the fight against Parkinson's disease in front of 400 people.

Celebrity Fight Night in Phoenix

Now a mainstay of fundraising events in the Valley, this year the gala set a record with 1,300 people in attendance and raised more than $9.1 million Saturday at JW Marriott Desert Ridge Resort and Spa in north Phoenix.

The money raised will go to the Muhammad Ali Parkinson Center at St. Joseph's Barrow Neurological Institute, as well as other charities.

The 10,000-square-foot facility, established in 1997 and named after the former heavyweight boxing champion, who was diagnosed with Parkinson's in 1984, is on the campus of St. Joseph's Hospital and Medical Center in Phoenix.

The progressive disorder of the brain can cause tremors, rigidity, poor posture and coordination, and difficulty performing voluntary movements.

Saturday's Fight Night XVIII was a black-tie affair featuring stars from many walks of life -- athletes, actors and comedians -- mingling with Valley residents. Celebrities like Evander Holyfield, Billy Crystal, Bo Derek and Kurt Warner walked the red carpet.

Go here to see the original:
Muhammad Ali's Celebrity Fight Night targets disease

Area man with Parkinson's to race to the clouds

WAPELLO - Despite having Parkinson's disease, Wapello native Jeff Weikert plans to race a motorcycle this summer for the final time.

"It's kind of a drug, and you get addicted to it," Weikert said. "I've raced pretty much everything from cars to motorcycles pretty much my whole life."

On July 8, Weikert will get the chance to race a motorcycle in the 90th annual Pike's Peak International Hill Climb in Colorado Springs, Colo.

"I want to show people that someone with Parkinson's disease can still compete," Weikert said.

Advertisement

The race is run on a 12.42-mile course with 156 turns that begins at 9,390 feet only to finish at the 14,110-foot summit of Pikes Peak.

Payne's Cycle Center out of Rock Island, Ill., has rebuilt the Honda 250cc Cheney-framed bike he will be riding.

This year, the race has 16 classes and features a variety of automotive, exhibition, open wheel, super stock car and motorcycle classes with a field approaching 200 competitors.

Weikert, 50, was diagnosed with early-onset Parkinson's disease in March 2009.

According to the Mayo Clinic, Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, often starting with a barely noticeable tremor in just one hand.

Read this article:
Area man with Parkinson's to race to the clouds

Area man with Parkinson’s to race to the clouds

WAPELLO - Despite having Parkinson's disease, Wapello native Jeff Weikert plans to race a motorcycle this summer for the final time.

"It's kind of a drug, and you get addicted to it," Weikert said. "I've raced pretty much everything from cars to motorcycles pretty much my whole life."

On July 8, Weikert will get the chance to race a motorcycle in the 90th annual Pike's Peak International Hill Climb in Colorado Springs, Colo.

"I want to show people that someone with Parkinson's disease can still compete," Weikert said.

Advertisement

The race is run on a 12.42-mile course with 156 turns that begins at 9,390 feet only to finish at the 14,110-foot summit of Pikes Peak.

Payne's Cycle Center out of Rock Island, Ill., has rebuilt the Honda 250cc Cheney-framed bike he will be riding.

This year, the race has 16 classes and features a variety of automotive, exhibition, open wheel, super stock car and motorcycle classes with a field approaching 200 competitors.

Weikert, 50, was diagnosed with early-onset Parkinson's disease in March 2009.

According to the Mayo Clinic, Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, often starting with a barely noticeable tremor in just one hand.

Read this article:
Area man with Parkinson's to race to the clouds

Multiple Sclerosis still is disease with many mysteries: Your Turn

By Mel Maurer

Guest Columnist

March is Multiple Sclerosis Awareness Month in Ohio.

Why? Our state has a very high incidence of MS one of the highest in the nation. Of the estimated 400,000 people in this country with MS, an estimated 18,000 live in Ohio. Whatever it is that brings MS to more people in Northeast climates is still unknown as is much about MS in general.

We do know that MS is a chronic disease that attacks the central nervous system (brain, spinal cord and optic nerves).

Signs and symptoms may include numbness or weakness in one or more limbs; partial or complete loss of vision, usually in one eye at a time (often with pain during eye movement); double vision or blurring of vision; tingling or pain in parts of your body; electric-shock sensations that occur with certain head movements; tremor, lack of coordination or unsteady gait; fatigue and dizziness.

Once thought to be a disease of young adults, we now know MS hits a wider range of ages.

MS, using the bodys own defense system, attacks the myelin sheath that surrounds and protects nerve fibers. The nerve fibers may also be damaged. The damaged myelin forms scar tissue (sclerosis), which gives the disease its name. When any part of the myelin sheath or nerve fiber is damaged or destroyed, communications to and from the brain and spinal cord are either distorted or interrupted.

I first became aware of Multiple Sclerosis in the fall of 1967 in a doctors small consulting room at University Hospitals when a neurologist, after examining my wife, Elaine, told us she had the disease. I had heard of it but I knew nothing about what it meant. Elaine knew more than that her best friends mother had MS and had been in a wheelchair for years.

The doctor, who would go on to become a nationally known authority on MS, warned us not to read up on the disease. He told us that most of what was written about it was about the severe form of MS, while in fact it could take many forms. Since then, research has identified four distinct courses of the disease: relapsing-remitting, primary progressive, secondary progressive and progressive relapsing.

View original post here:
Multiple Sclerosis still is disease with many mysteries: Your Turn

Angioplasty may help ease symptoms of multiple sclerosis

Washington, March 26 : A minimally invasive endovascular treatment for chronic cerebrospinal venous insufficiency is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with multiple sclerosis, say scientists.

Chronic cerebrospinal venous insufficiency (CCSVI) is a condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart.

Researchers investigated the connection between CCSVI and multiple sclerosis MS.

MS is typically treated with disease-modifying drugs, which modulate or suppress the immune response believed to be central in the progression of the disease.

"Traditional theories surrounding treatment for multiple sclerosis in large part focus on autoimmune causes for brain pathology and neurologic symptoms. Based on this, treatment has been predominantly medications by mouth or injection," stated Kenneth Mandato, M.D., an interventional radiologist at Albany Medical Center in Albany, N.Y.

"Interventional radiologists, pioneers in the field of minimally invasive therapies, have been performing an endovascular therapy called angioplasty for years, to treat blocked or narrowed arteries and veins. We have been using angioplasty to open jugular and azygos veins in the neck and chest respectively to improve blood flow in people with MS. On follow-up, we have seen many of these individuals report significant symptom relief," he added.

Classifications within a diagnosis of MS include primary progressive, which means a gradually progressive disease without remission; relapsing remitting, which demonstrates acute attacks with intervals of slow improvements in symptoms; secondary progressive, where a disease that was once relapsing remitting is now slowly progressing.

MS subtypes within the Albany study group included 96 individuals with relapsing remitting, 66 with secondary progressive and 30 with primary progressive.

The study population included those who underwent angioplasty alone and three who underwent angioplasty with a stent (a tiny mesh tube used to hold the vessel open) placement.

See more here:
Angioplasty may help ease symptoms of multiple sclerosis

Funding doubled in effort to defeat dementia crisis

Funding for dementia research will be more than doubled by 2015 to tackle "one of the greatest challenges of our time" and make Britain a world leader in the field, David Cameron will announce today.

Declaring the problem a personal priority, the Prime Minister will say there must be a collective fight against the "quiet crisis", in the same way there was against cancer and HIV. Thought to affect 670,000 people although about 400,000 have not been diagnosed and do not know they have it dementia is estimated to cost the UK 23bn a year. The number affected is expected to rise to one million in the next 10 years.

Launching a "national challenge on dementia", Mr Cameron will say funding for dementia research will reach 66m by 2015, from 26.6m 2010.

"One of the greatest challenges ... is what I'd call the quiet crisis, one that steals lives and tears at the hearts of families, but that relative to its impact is hardly acknowledged," he will say today. He will say that dementia is a terrible disease and it is a scandal that the UK has failed to keep pace with it.

"It is as though we've been in collective denial," Mr Cameron will declare. Labelling the issue a "national crisis", he will add that there needs to be an all-out fight-back against this disease that cuts across society. "We did it with cancer in the 70s. With HIV in the 80s and 90s. We fought the stigma, stepped up to the challenge and made massive in-roads into fighting these killers. Now we've got to do the same with dementia," Mr Cameron will say.

Jeremy Hughes, chief executive of the Alzheimer's Society, said that it was "an unprecedented step".

Mr Hughes said: "Doubling funding for [dementia] research, tackling diagnosis and calling for a radical shift in the way we talk, think and act on dementia will help to transform lives."

Excerpt from:
Funding doubled in effort to defeat dementia crisis

Dementia is a national crisis like HIV and cancer, says David Cameron

As the NHS struggles with this cost, Mr Cameron plans to improve research on living with dementia and fund a new academic centre for scientists to investigate the causes of the condition.

He also wants to encourage people to volunteer for brain scanning to help identify the signs of early onset.

We did it with cancer in the 70s. With HIV in the 80s and 90s, he will say. We fought the stigma, stepped up to the challenge and made massive in-roads into fighting these killers.

Now weve got to do the same with dementia. This is a personal priority of mine.

The number of people suffering from the condition is likely to reach a million within a decade, but only around one in four will get a correct diagnosis.

Dementia is simply a terrible disease, he will say. And it is a scandal that we as a country havent kept pace with it. The level of diagnosis, understanding and awareness of dementia is shockingly low. It is as though weve been in collective denial.

So my argument today is that weve got to treat this like the national crisis it is. We need an all-out fight-back against this disease; one that cuts across society."

Shirley Cramer, chief executive of Alzheimers Research UK, said the new money was crucial to "if we are to avert the drastic economic costs of dementia that lie in wait".

Emergency hospital admissions for dementia sufferers have risen sharply in recent years.

Experts say the increasing number of admissions is costly to the NHS and in many cases unnecessary, as well as traumatic for vulnerable patients.

Read more:
Dementia is a national crisis like HIV and cancer, says David Cameron

Cameron Pledges Huge Dementia Research Funding Boost

David Cameron has called the problem of dementia a "national crisis"

Funding for research into dementia is to be more than doubled by 2015 in a bid to make Britain a world leader in the field, David Cameron will announce.

The prime minister will declare on Monday that tackling the "national crisis" posed by the disease is one of his personal priorities.

He will say it is a "scandal" that the UK has not done more to address dementia, which is thought to affect 670,000 people although about 400,000 have not been diagnosed and do not know they have it. The cost to UK society is estimated at 23 billion.

Over the next 10 years, the number with the disease is expected to rise to one million.

Launching a "national challenge on dementia", Mr Cameron will set out plans to step up research into cures and treatments and to ensure that the health and social care systems are equipped to deal with the problem.

Overall funding for dementia research is to reach 66m by 2015, from 26.6 in 2010.

"One of the greatest challenges of our time is what I'd call the quiet crisis, one that steals lives and tears at the hearts of families, but that relative to its impact is hardly acknowledged," he will say.

"Dementia is simply a terrible disease. And it is a scandal that we as a country haven't kept pace with it. The level of diagnosis, understanding and awareness of dementia is shockingly low. It is as though we've been in collective denial."

The prime minister will say that the costs associated with the disease are already higher than those for cancer, heart disease or stroke.

Read more here:
Cameron Pledges Huge Dementia Research Funding Boost

Nationwide dementia screening to tackle 'crisis' among elderly

Screening will also be introduced into the NHS health check programme for people aged 40 to 74.

Mr Lansley told the Daily Mail: When you talk to people about their concerns for the future, its evident that dementia is a bigger concern even than having cancer.

We are looking for early diagnosis where physiological signs might not be as easy to pick up.

We are increasingly able to support people with early diagnosis to sustain their memory and their overall mental agility.

Sufferers of dementia, which causes the mind to deteriorate, currently fill a quarter of all hospital beds.

Health ministers are also concerned that the 19 billion cost of treating Britains 67,000 dementia patients every year is higher than that of treating cancer, heart disease or stroke sufferers.

Alzheimer's Disease is the most common cause of dementia and the most feared complaint among people over the age of 55 in the UK, behind cancer and stroke. However, only one in four people with the illness are diagnosed.

As the NHS struggles with this cost, Mr Cameron plans to improve research on living with dementia and fund a new academic centre for scientists to investigate the causes of the condition.

He also wants to encourage people to volunteer for brain scanning to help identify the signs of early onset.

We did it with cancer in the 70s. With HIV in the 80s and 90s, he will say. We fought the stigma, stepped up to the challenge and made massive inroads into fighting these killers.

Excerpt from:
Nationwide dementia screening to tackle 'crisis' among elderly

Nationwide dementia screening to tackle ‘crisis’ among elderly

Screening will also be introduced into the NHS health check programme for people aged 40 to 74.

Mr Lansley told the Daily Mail: When you talk to people about their concerns for the future, its evident that dementia is a bigger concern even than having cancer.

We are looking for early diagnosis where physiological signs might not be as easy to pick up.

We are increasingly able to support people with early diagnosis to sustain their memory and their overall mental agility.

Sufferers of dementia, which causes the mind to deteriorate, currently fill a quarter of all hospital beds.

Health ministers are also concerned that the 19 billion cost of treating Britains 67,000 dementia patients every year is higher than that of treating cancer, heart disease or stroke sufferers.

Alzheimer's Disease is the most common cause of dementia and the most feared complaint among people over the age of 55 in the UK, behind cancer and stroke. However, only one in four people with the illness are diagnosed.

As the NHS struggles with this cost, Mr Cameron plans to improve research on living with dementia and fund a new academic centre for scientists to investigate the causes of the condition.

He also wants to encourage people to volunteer for brain scanning to help identify the signs of early onset.

We did it with cancer in the 70s. With HIV in the 80s and 90s, he will say. We fought the stigma, stepped up to the challenge and made massive inroads into fighting these killers.

Excerpt from:
Nationwide dementia screening to tackle 'crisis' among elderly

£66m pledge for dementia research

26 March 2012 Last updated at 03:20 ET

Please turn on JavaScript. Media requires JavaScript to play.

Care Services Minister Paul Burstow: "Making dementia a national priority... is the way we can tackle this"

Funding for research into dementia is to be doubled to 66m by 2015 to try to make the UK a world leader in the field, David Cameron will announce.

The prime minister is expected to say in a speech that the level of diagnosis, understanding and awareness of dementia is "shockingly low".

Dementia is thought to affect around 800,000 people in the UK, with the cost to society estimated at 23bn.

In the next decade, the number with the disease is expected to top one million.

Mr Cameron will set out plans to step up research into cures and treatments and to ensure that the health and social care systems are equipped to deal with the problem.

Mr Cameron will say: "One of the greatest challenges of our time is what I'd call the quiet crisis, one that steals lives and tears at the hearts of families, but that relative to its impact is hardly acknowledged.

"Dementia is simply a terrible disease. And it is a scandal that we as a country haven't kept pace with it.

Read the rest here:
£66m pledge for dementia research